AbbVie Reports First-Quarter 2015 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/8/2026

1. LEVI
2. NVDA
3. USO
4. STZ
5. GOOGL
6. SPY
7. APLD
8. MSFT
9. SPCX
10. AGNT

Go back to AbbVie Reports First-Quarter 2015 Financial Results

Abbvie (ABBV) Weakness Related to Hep-C Data from Gilead (GILD), BMO Capital Says

April 23, 2015 11:47 AM EDT

BMO Capital analyst Alex Arfaei weighed in on Abbvie (NYSE: ABBV) following Q1 results. The analyst said Street Hep-C numbers need to come down although the bullish thesis is intact.

Arfaei commented, "ABBV shares are down about 2% as we prepare this note, despite the company reporting strong 1Q15 results. We believe the weakness is likely related to new Hep-C data released from Gilead (NASDAQ: GILD)."

He continued, "A Phase 2... More